All sites C00-96,D32-33,D42-43,D45-47,D76 520 90.0 2.3 3.2 0.9 3.6
Mouth, pharynx C00-14 7 97.1 - 2.9 - -
  Lip C00 2 88.9 - 11.1 - -
  Tongue C02 2 100.0 - - - -
  Mouth, other C03-06 1 100.0 - - - -
  Salivary glands C07-08 0 100.0 - - - -
  Pharynx C01,C09-14 2 100.0 - - - -
Digestive organs C15-26 107 86.8 0.9 6.5 1.7 4.1
  Oesophagus C15 5 96.3 - - - 3.7
  Stomach C16 13 95.2 - 3.2 1.6 -
  Small intestine C17 3 100.0 - - - -
  Colon C18 37 95.7 - 2.1 1.1 1.1
  Rectum, rectosigmoid C19-20 21 98.1 - - - 1.9
  Anus C21 0 100.0 - - - -
  Liver C22 8 68.4 5.3 15.8 7.9 2.6
  Gallbladder, bile ducts C23-24 3 46.7 - 20.0 - 33.3
  Pancreas C25 16 54.4 3.8 24.1 3.8 13.9
  Other digestive organs C26 1 75.0 - 25.0 - -
Respiratory organs C30-39 58 67.7 9.7 11.1 1.7 9.7
  Nose, sinuses C30-31 0 100.0 - - - -
  Larynx, epiglottis C32 3 100.0 - - - -
  Lung, trachea C33-34 53 66.2 10.2 12.0 1.9 9.8
  Mediastinum, pleura C38 1 33.3 33.3 - - 33.3
Bone C40-41 1 100.0 - - - -
Melanoma of the skin C43 16 100.0 - - - -
Skin, non-melanoma C44 25 99.2 - - - 0.8
Mesothelioma C45 3 100.0 - - - -
Autonomic nervous system C47 0 100.0 - - - -
Soft tissues C48-49 3 100.0 - - - -
Breast C50 0 100.0 - - - -
Male genital organs C60-63 173 99.5 - - 0.1 0.3
  Prostate C61 168 99.5 - - 0.1 0.4
  Testis C62 5 100.0 - - - -
  Other male genital C60,C63 1 100.0 - - - -
Urinary organs C64-68 51 94.9 0.4 1.9 0.8 1.9
  Kidney C64 12 91.7 - 3.3 1.7 3.3
  Bladder and urinary tract2 C65-68 39 95.9 0.5 1.5 0.5 1.5
Eye C69 1 71.4 - 28.6 - -
Brain, central nervous system C70-72,D32-33,D42-43 16 87.2 - 5.1 1.3 6.4
Thyroid gland C73 4 95.0 5.0 - - -
Other endocrine glands C74-75 0 100.0 - - - -
Illdefined or unknown C76,C80 9 75.6 2.2 6.7 - 15.6
Lymphoid and haematopoietic tissue C81-96,D45-47,D76 44 76.3 11.0 0.5 2.3 10.0
  Hodgkin lymphoma C81 3 100.0 - - - -
  Non-Hodgkin lymphoma C82-86,C96,D76 19 100.0 - - - -
  Malignant immunoproliferative diseases C88 1 60.0 20.0 - - 20.0
  Myeloma and other plasma cell tumors C90 6 56.7 13.3 3.3 6.7 20.0
  Leukaemia C91-95 11 53.7 33.3 - 3.7 9.3
  Myelodysplastic syndromes D46 2 45.5 9.1 - - 45.5
  Myeloproliferaitive neoplasms D45,D47 2 25.0 - - 12.5 62.5
Not included above
  Basal cell carcinoma of the skin 109 100.0 - - - -
1 The following order of preference for confirmation of the diagnosis is used:
1. Histology (including autopsy, and bone marrow and blood smear examination in leukaemias)
2. Cytology
3. Surgery (including endoscopy), autopsy without histology, X-ray and some specified laboratory examinations
4. Clinical examination only
2 PUNLMP and ca in situ of the uroepithelium are included.